| European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia A Hochhaus, M Baccarani, RT Silver, C Schiffer, JF Apperley, F Cervantes, ... Leukemia 34 (4), 966-984, 2020 | 1232 | 2020 |
| The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts Experts in Chronic Myeloid Leukemia Blood, The Journal of the American Society of Hematology 121 (22), 4439-4442, 2013 | 689 | 2013 |
| Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial S Saussele, J Richter, J Guilhot, FX Gruber, H Hjorth-Hansen, A Almeida, ... The Lancet Oncology 19 (6), 747-757, 2018 | 548 | 2018 |
| Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up A Hochhaus, S Saussele, G Rosti, FX Mahon, JJWM Janssen, ... Annals of Oncology 28, iv41-iv51, 2017 | 394 | 2017 |
| The concept of treatment-free remission in chronic myeloid leukemia S Saußele, J Richter, A Hochhaus, FX Mahon Leukemia 30 (8), 1638-1647, 2016 | 298 | 2016 |
| Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008 M Björkholm, L Ohm, S Eloranta, Å Derolf, M Hultcrantz, J Sjöberg, ... Journal of Clinical Oncology 29 (18), 2514, 2011 | 249 | 2011 |
| Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia M Ilander, U Olsson-Strömberg, H Schlums, J Guilhot, O Brück, ... Leukemia 31 (5), 1108-1116, 2017 | 243 | 2017 |
| Tumor necrosis factor-induced degranulation in adherent human neutrophils is dependent on CD11b/CD18-integrin-triggered oscillations of cytosolic free Ca2+. J Richter, J Ng-Sikorski, I Olsson, T Andersson Proceedings of the National Academy of Sciences 87 (23), 9472-9476, 1990 | 238 | 1990 |
| Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein M Järås, P Johnels, N Hansen, H Ågerstam, P Tsapogas, M Rissler, ... Proceedings of the National Academy of Sciences 107 (37), 16280-16285, 2010 | 221 | 2010 |
| Murine models of acute neuronopathic Gaucher disease IB Enquist, CL Bianco, A Ooka, E Nilsson, JE Månsson, M Ehinger, ... Proceedings of the National Academy of Sciences 104 (44), 17483-17488, 2007 | 201 | 2007 |
| Effective cell and gene therapy in a murine model of Gaucher disease IB Enquist, E Nilsson, A Ooka, JE Månsson, K Olsson, M Ehinger, ... Proceedings of the National Academy of Sciences 103 (37), 13819-13824, 2006 | 166 | 2006 |
| Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation. J Richter, T Andersson, I Olsson Journal of immunology (Baltimore, Md.: 1950) 142 (9), 3199-3205, 1989 | 157 | 1989 |
| Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia J Flygare, T Kiefer, K Miyake, T Utsugisawa, I Hamaguchi, L Da Costa, ... Blood 105 (12), 4627-4634, 2005 | 155 | 2005 |
| Musculoskeletal pain in patients with chronic myeloid leukemia after discontinuation of imatinib: a tyrosine kinase inhibitor withdrawal syndrome J Richter, S Söderlund, A Lübking, A Dreimane, K Lotfi, B Markevärn, ... J Clin Oncol 32 (25), 2821-2823, 2014 | 150 | 2014 |
| Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry M Höglund, F Sandin, K Hellström, M Björeman, M Björkholm, M Brune, ... Blood, The Journal of the American Society of Hematology 122 (7), 1284-1292, 2013 | 150 | 2013 |
| Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia P Jaako, J Flygare, K Olsson, R Quere, M Ehinger, A Henson, S Ellis, ... Blood, The Journal of the American Society of Hematology 118 (23), 6087-6096, 2011 | 145 | 2011 |
| Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells M Nilsson, J Ljungberg, J Richter, T Kiefer, M Magnusson, A Lieber, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2004 | 145 | 2004 |
| Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML R Warfvinge, L Geironson, MNE Sommarin, S Lang, C Karlsson, ... Blood, The Journal of the American Society of Hematology 129 (17), 2384-2394, 2017 | 138 | 2017 |
| Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia H Ågerstam, C Karlsson, N Hansen, C Sandén, M Askmyr, S von Palffy, ... Proceedings of the National Academy of Sciences 112 (34), 10786-10791, 2015 | 124 | 2015 |
| α10 Integrin Expression Is Up-Regulated on Fibroblast Growth Factor-2-Treated Mesenchymal Stem Cells with Improved Chondrogenic Differentiation Potential L Varas, LB Ohlsson, G Honeth, A Olsson, T Bengtsson, C Wiberg, ... Stem cells and development 16 (6), 965-978, 2007 | 121 | 2007 |
Stefan KarlssonProfessor of Molecular Medicine, Lund UniversityVerified email at med.lu.se
